Compile Data Set for Download or QSAR
Report error Found 32 Enz. Inhib. hit(s) with all data for entry = 50039418
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345679((3-endo)-3-[2-Hydroxy-2,2-bis(2-methylphenyl)ethyl...)
Affinity DataIC50: 10nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345681((3-endo)-1,1-Bis-(3-fluorophenyl)-2-(8,8-dimethyl-...)
Affinity DataIC50: 11nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345689((3-endo)-1,1-Bis-(3-thienyl)-2-(8,8-dimethyl-8-azo...)
Affinity DataIC50: 17nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345677(2-(endo-8-methyl-8-azabicyclo[3.2.1]octan-3-yl)-1-...)
Affinity DataIC50: 19nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345691((3-endo)-3-[2-Hydroxy-2,2-bis(2-methylphenyl)ethyl...)
Affinity DataIC50: 23nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345682((3-endo)-3-[2,2-Bis(3-chlorophenyl)-2-hydroxyethyl...)
Affinity DataIC50: 25nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345686((3-endo)-1,1-Bis(5-fluoro-2-methylphenyl)-2-(8,8-d...)
Affinity DataIC50: 37nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345685((3-endo)-1,1-Bis(3-fluoro-2-methylphenyl)-2-(8,8-d...)
Affinity DataIC50: 65nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345690((3-endo)-3-[2-Hydroxy-2,2-bis(4-methyl-3-thienyl)e...)
Affinity DataIC50: 65nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345684((3-endo)-1,1-Bis-(4-chlorophenyl)-2-(8,8-dimethyl-...)
Affinity DataIC50: 74nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345687((3-endo)-3-[2,2-Bis(3,5-difluorophenyl)-2-hydroxye...)
Affinity DataIC50: 112nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345676(3-(endo-8-methyl-8-azabicyclo[3.2.1]octan-3-yl)-1,...)
Affinity DataIC50: 134nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345678(1-(endo-8-methyl-8-azabicyclo[3.2.1]octan-3-yl)-2-...)
Affinity DataIC50: 135nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50297133(endo-8-methyl-3-(2,2,2-triphenylethyl)-8-azabicycl...)
Affinity DataIC50: 206nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345688((3-endo)-1,1-Bis(3,4-difluorophenyl)-2-(8,8-dimeth...)
Affinity DataIC50: 290nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50297134(endo-3-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)-2,...)
Affinity DataIC50: 687nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50297135(endo-N-benzyl-3-(8-methyl-8-azabicyclo[3.2.1]octan...)
Affinity DataIC50: 839nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345674(1,1-diphenyl-2-(3-tropanyl)ethanol | 2-(endo-8-met...)
Affinity DataIC50: 973nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50297131(endo-N-(3-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)...)
Affinity DataIC50: 1.06E+3nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50297128(endo-1-benzyl-3-(3-(8-methyl-8-azabicyclo[3.2.1]oc...)
Affinity DataIC50: 1.34E+3nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345675((endo-8-methyl-8-azabicyclo[3.2.1]octan-3-yl)diphe...)
Affinity DataIC50: 1.50E+3nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50297129(endo-1-ethyl-3-(3-(8-methyl-8-azabicyclo[3.2.1]oct...)
Affinity DataIC50: 1.94E+3nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50297132(endo-N-(3-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)...)
Affinity DataIC50: 2.73E+3nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50297130(endo-N-(3-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)...)
Affinity DataIC50: 2.90E+3nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345683((3-endo)-3-{2-Hydroxy-2,2-bis[4-(methyloxy)phenyl]...)
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345680((3-endo)-3-{2-Hydroxy-2,2-bis[2-(methyloxy)phenyl]...)
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity against human M3 receptor expressed in CHO cells assessed as inhibition of acetylcholine-induced calcium mobilization by FLIPRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345693((3-endo)-3-(2-Cyano-2,2-diphenylethyl)-8,8-dimethy...)
Affinity DataKi:  0.0500nMAssay Description:Displacement of [3H]N-methyl Scopolamine from human muscarinic M1 receptor expressed in CHO cells by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345693((3-endo)-3-(2-Cyano-2,2-diphenylethyl)-8,8-dimethy...)
Affinity DataKi:  0.0600nMAssay Description:Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345693((3-endo)-3-(2-Cyano-2,2-diphenylethyl)-8,8-dimethy...)
Affinity DataKi:  0.170nMAssay Description:Displacement of [3H]N-methyl Scopolamine from human muscarinic M2 receptor expressed in CHO cells by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345692((3-endo)-3-(2,2-Di-2-thienylethenyl)-8,8-dimethyl-...)
Affinity DataKi:  0.380nMAssay Description:Displacement of [3H]N-methyl Scopolamine from human muscarinic M1 receptor expressed in CHO cells by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345692((3-endo)-3-(2,2-Di-2-thienylethenyl)-8,8-dimethyl-...)
Affinity DataKi:  0.450nMAssay Description:Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50345692((3-endo)-3-(2,2-Di-2-thienylethenyl)-8,8-dimethyl-...)
Affinity DataKi:  0.730nMAssay Description:Displacement of [3H]N-methyl Scopolamine from human muscarinic M2 receptor expressed in CHO cells by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2013
Entry Details Article
PubMed